Ching‐Piao Tsai
- Neurology top 2%
- Peripheral Neuropathies and Disorders 12
- Amyotrophic Lateral Sclerosis Research 4
- Long-Term Effects of COVID-19 2
- Autoimmune Neurological Disorders and Treatments 1
-
- Multiple Sclerosis Research Studies 10
- Neurology top 10%
- Peripheral Neuropathies and Disorders 12
- Amyotrophic Lateral Sclerosis Research 4
- Long-Term Effects of COVID-19 2
- Autoimmune Neurological Disorders and Treatments 1
- Genetics top 10%
- Neurogenetic and Muscular Disorders Research 4
- Rheumatology top 10%
- Systemic Lupus Erythematosus Research 2
-
- Ocular Diseases and Behçet’s Syndrome 2
- Co-authors
- Benjamin GreenbergKazuo FujiharaTakashi YamamuraBeata Zakrzewska‐PniewskaJ. de SèzeAlbert SaizYuichi KawataIngo Kleiter
- Partner nations
- TaiwanUnited StatesJapan
In The Last Decade
Ching‐Piao Tsai
21 papers receiving 904 citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Neurology 604
- Pathology and Forensic Medicine 492
- Neurology 111
- Genetics 121
- Rheumatology 150
Countries citing papers authored by Ching‐Piao Tsai
This map shows the geographic impact of Ching‐Piao Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Piao Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Piao Tsai more than expected).
Fields of papers citing papers by Ching‐Piao Tsai
This network shows the impact of papers produced by Ching‐Piao Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Piao Tsai. The network helps show where Ching‐Piao Tsai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ching‐Piao Tsai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 9 | |
| 2 | 2019 | 9 | |
| 3 | Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorderbreakdown → | 2019 | 415 |
| 4 | 2019 | 8 | |
| 5 | 2015 | 76 | |
| 6 | 2015 | 9 | |
| 7 | 2013 | 33 | |
| 8 | 2013 | 2 | |
| 9 | 2013 | 46 | |
| 10 | 2012 | 78 | |
| 11 | 2011 | 16 | |
| 12 | 2011 | 7 | |
| 13 | 2011 | 25 | |
| 14 | 2006 | 11 | |
| 15 | Multiple sclerosis in Taiwan. | 2004 | 51 |
| 16 | Guillain-Barré syndrome: a retrospective, hospital-based study. | 2002 | 3 |
| 17 | 2000 | 35 | |
| 18 | 1996 | 45 | |
| 19 | 1994 | 35 | |
| 20 | 1993 | 11 |
About Ching‐Piao Tsai
Ching‐Piao Tsai is a scholar working on Neurology, Pathology and Forensic Medicine and Genetics, having authored 21 papers that have together received 926 indexed citations. Recurring topics across this work include Peripheral Neuropathies and Disorders (12 papers), Multiple Sclerosis Research Studies (10 papers), Neurogenetic and Muscular Disorders Research (4 papers), Amyotrophic Lateral Sclerosis Research (4 papers), Systemic Lupus Erythematosus Research (2 papers), Ocular Diseases and Behçet’s Syndrome (2 papers), Long-Term Effects of COVID-19 (2 papers) and Autoimmune Neurological Disorders and Treatments (1 paper). The work is most often cited by research in Neurology (604 citations), Pathology and Forensic Medicine (492 citations) and Neurology (111 citations). Ching‐Piao Tsai has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Benjamin Greenberg, Kazuo Fujihara, Takashi Yamamura, Beata Zakrzewska‐Pniewska, J. de Sèze, Albert Saiz, Yuichi Kawata, Ingo Kleiter, Hayato Yamazaki and Pádraig Wright. Their work appears in journals such as New England Journal of Medicine, PLoS ONE and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.